Expert Pitch
West Virginia University

Celebrities, athletes and public figures with COVID-19 influence public perception of the virus

19-Mar-2020 2:25 PM EDT, by West Virginia University

MORGANTOWN, W. Va. - Within 48 hours of actors Tom Hanks and Rita Wilson announcing they tested positive for the novel coronavirus, one West Virginia University expert launched into research mode. 

Elizabeth Cohen, associate professor in the Department of Communication Studies, has analyzed emotional responses to media and the attachments people have to celebrities and fictional characters. Through her research, Cohen has connected celebrity effects on public health and behavior.

Now that a famous figure had tested positive for COVID-19, how would the general public’s perception of the potentially deadly virus change, if at all? 

“There have now been a lot of well-known individuals testing positive COVID-19, and of course there will be more,” Cohen said. “On one hand, these announcements may help make people understand how far-reaching the virus is. Or they can make people think ‘celebrities are just like us. If Tom Hanks can get it, I can get it’ On the other hand, it could make it seem like not such a big deal.”

Cohen created an online experiment through Amazon Mechanical Turk, a crowdsourcing service that researchers can utilize to gather data. She assigned half of the participants to read a basic statement about COVID-19 that included verbiage that Hanks tested positive for it. The other half of the participants read the same sentence except that Hanks’ name was swapped out with a random, regular “Joe Schmo” type of name.

She then asked participants their risk assessment of COVID-19, and whether they thought they were more susceptible to the virus or more concerned about it spreading to their loved ones after reading the statements.

Cohen plans to continue studying the issue and will eventually publish her findings.

“There’s evidence that celebrities are indicators of what’s acceptable,” Cohen said. “I think here we’re seeing an increase of risk but not necessarily severity, with Tom Hanks as an example. Knowing a celebrity has it raises a level of awareness.”

Hanks and his spouse, Wilson, were the first major celebrities to announce they’d tested positive for COVID-19. Idris Elba, star of “The Wire” and “Luther,” revealed he tested positive on Monday (March 16). Several athletes, including NBA superstars Kevin Durant and Rudy Gobert, have also tested positive. 

Cohen referenced how the public began to perceive HIV from a more compassionate, understanding viewpoint when Magic Johnson announced his retirement from the NBA in 1991 after contracting the virus.

“There were at least 20 studies in the early 90s that came out looking at how it affected the perceptions and behaviors toward HIV,” she said.

The same happened with suicide and mental illness following the death of comedian Robin Williams in 2014.

“Whether you want to believe it or not, celebrities have an effect on people’s social norms,” Cohen said. 

Recently, she’s studied the perceptions of vaping and preliminary results found that showing celebrities vaping made it more acceptable.

Even the president, Donald Trump, and his actions can influence how Americans react to the threat of coronavirus, Cohen added. 

“He’s a celebrity, too,” she said. “And he has changed over the last few weeks. He pushed back on being tested when he first had the opportunity. But then he got tested. How he responds to it himself can be very influential on the public’s behaviors.” 

-WVU-

js/03/19/20

CONTACT: Elizabeth Cohen Associate Professor, Communication Studies WVU Eberly College of Arts and Sciences Elizabeth.Cohen@mail.wvu.edu

OR

Jake Stump Director, Research Communications University Relations-Communications 304-293-5507; Jake.Stump@mail.wvu.edu

 

Call 1-855-WVU-NEWS for the latest West Virginia University news and information from WVUToday.

Follow @WVUToday on Twitter.




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.15981